Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-198959
Filing Date
2024-08-12
Accepted
2024-08-12 16:59:03
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d878941ds3.htm S-3 191115
2 EX-5.1 d878941dex51.htm EX-5.1 8107
3 EX-23.1 d878941dex231.htm EX-23.1 1321
4 EX-FILING FEES d878941dexfilingfees.htm EX-FILING FEES 33665
5 GRAPHIC g878941g03g03.jpg GRAPHIC 46915
6 GRAPHIC g878941g0807100504435.jpg GRAPHIC 2413
  Complete submission text file 0001193125-24-198959.txt   303397
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281493 | Film No.: 241197724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)